ClinConnect ClinConnect Logo
Search / Trial NCT05397951

The Validation Study of Bioelectronics

Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · May 25, 2022

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Sensor Non Invasive Multi Modality Vital Signs Safe Wearability Optoelectronic System Optical Polarimetry Near Infrared Spectroscopy Skin Interfaced Wearable

ClinConnect Summary

This clinical trial, called the Validation Study of Bioelectronics, is looking at new sensors that can be worn on the body to see how safe and effective they are for healthy individuals. The sensors are designed to track various health behaviors, and the researchers want to make sure they are comfortable and function well when worn. The study is currently recruiting participants aged 18 to 99 who are in good health, meaning they do not have any serious illnesses.

If you join the study, you will wear these sensors for a short time and help researchers understand how well they work. To be eligible, you should not be pregnant, have any skin conditions that could be worsened by wearing the sensors, or have had allergic reactions to certain materials in the past. Participants will also need to be able to perform daily activities and participate in some moderate exercise for a short duration. This study is a great opportunity to contribute to research that could improve health monitoring technology in the future!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Individuals with ages between 18 and 99.
  • Healthy individuals (not known to suffer any significant illness relevant to the proposed study).
  • Exclusion Criteria:
  • Pregnant or lactating.
  • History of active (clinically significant) skin disorders that make skin vulnerable to contact conventional electronic devices.
  • History of allergic response to silicones or adhesives (such as 3M Tegaderm).
  • Broken, damaged or irritated skin or rashes near the sensor application sites (finger, wrist, temple, subclavian, arm, neck, and thigh).
  • Subjects who are physically or cognitively unable to normally perform activities of daily living, assessed at the discretion of the investigator to ensure safe completion of study tasks.
  • Subjects who are unable to participate in moderate exercise for 6 minutes.

About University Of North Carolina, Chapel Hill

The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.

Locations

Chapel Hill, North Carolina, United States

Patients applied

AW

1 patients applied

Trial Officials

Wubin Bai, PhD

Principal Investigator

Assistant Professor of Applied Physical Sciences

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials